MettlerToledo International (MTD)
(Delayed Data from NYSE)
$1,435.94 USD
+12.50 (0.88%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1,432.54 -3.40 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
MTD 1,435.94 +12.50(0.88%)
Will MTD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MTD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MTD
Mettler-Toledo (MTD) is a Top-Ranked Momentum Stock: Should You Buy?
Mettler-Toledo (MTD) is a Top-Ranked Momentum Stock: Should You Buy?
MTD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Mettler-Toledo and Bruker
2 Instruments Stocks to Watch From a Prospering Industry
Why Mettler-Toledo (MTD) International Revenue Trends Deserve Your Attention
Other News for MTD
The 10 most actionable policies if Harris wins this November - Jefferies
Baron Asset Fund Q2 2024 Shareholder Letter
S&P 500 stocks that return more capital than their cost of capital - BofA
GE HealthCare: Encouraging Long-Term Growth Prospects
GE Healthcare: Encouraging Long-Term Growth Prospects